Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nodular Basal Cell Carcinoma”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableNot Yet RecruitingNCT07384078
What this trial is testing

High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Disease in Adults

Who this might be right for
Superficial Basal Cell CarcinomaNodular Basal Cell CarcinomaBowen's Disease+2 more
Jussi Salonen 294
Post-approval studies (Phase 4)Study completedNCT00314756
What this trial is testing

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

Who this might be right for
Basal Cell Carcinoma
Wake Forest University 15
Not applicableActive Not RecruitingNCT04744935
What this trial is testing

Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma

Who this might be right for
Basal Cell CarcinomaSuperficial Basal Cell CarcinomaNodular Basal Cell Carcinoma
Christopher Zachary 40
Testing effectiveness (Phase 2)Study completedNCT01700049
What this trial is testing

Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes

Who this might be right for
Basal Cell Carcinoma
Mayo Clinic 28
Testing effectiveness (Phase 2)Ended earlyNCT01033019
What this trial is testing

To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)

Who this might be right for
Sporadic Superficial and Nodular Skin Basal Cell Carcinomas
Novartis Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT04552990
What this trial is testing

Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma

Who this might be right for
BCCBCC - Basal Cell CarcinomaBasal Cell Carcinoma+3 more
Memorial Sloan Kettering Cancer Center 16
Post-approval studies (Phase 4)Study completedNCT00204555
What this trial is testing

Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal Cell
University Hospital Tuebingen 100
Early research (Phase 1)Study completedNCT02018679
What this trial is testing

Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Basal Cell Carcinoma

Who this might be right for
Nodular Basal Cell Carcinoma
Dong-A University 34
Not applicableStudy completedNCT02270645
What this trial is testing

Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser

Who this might be right for
Nodular Basal Cell CarcinomaSuperficial Basal Cell Carcinoma
University of Miami 12
Large-scale testing (Phase 3)Study completedNCT01260987
What this trial is testing

Fractional CO2 Laser Assisted Photodynamic Therapy

Who this might be right for
Actinic KeratosisBasal Cell Carcinoma
Bispebjerg Hospital 47
Very early researchLooking for participantsNCT07144384
What this trial is testing

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Who this might be right for
Skin Basal Cell CarcinomaSkin Nodular Basal Cell CarcinomaSkin Squamous Cell Carcinoma
Kirsten Johnson 40
Testing effectiveness (Phase 2)Study completedNCT02550678
What this trial is testing

The Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma

Who this might be right for
Basal Cell Nevus SyndromeSkin NeoplasmNodular Basal Cell Carcinoma of Skin
Ascend Biopharmaceuticals Ltd 16
Not applicableWithdrawnNCT04510727
What this trial is testing

Optical Coherence Tomography Guided C&D

Who this might be right for
Basal Cell Carcinoma
University of Miami
Not applicableStudy completedNCT01482104
What this trial is testing

New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)

Who this might be right for
Skin NeoplasmsCarcinoma, Basal Cell
Norwegian University of Science and Technology 277
Large-scale testing (Phase 3)UnknownNCT02242929
What this trial is testing

Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma

Who this might be right for
Nodular Basal Cell Carcinoma
Maastricht University Medical Center 145
Testing effectiveness (Phase 2)Looking for participantsNCT05157763
What this trial is testing

Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

Who this might be right for
Superficial Basal Cell CarcinomaNodular Basal Cell Carcinoma
MediWound Ltd 32
Testing effectiveness (Phase 2)Study completedNCT00108121
What this trial is testing

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Peplin 60
Testing effectiveness (Phase 2)Study completedNCT02017964
What this trial is testing

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Who this might be right for
Desmoplastic/Nodular MedulloblastomaMedulloblastomaMedulloblastoma With Extensive Nodularity+1 more
Children's Oncology Group 26
Large-scale testing (Phase 3)Study completedNCT00066872
What this trial is testing

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

Who this might be right for
Non-melanomatous Skin Cancer
Queen's Medical Center 500
Large-scale testing (Phase 3)Study completedNCT00472043
What this trial is testing

PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma

Who this might be right for
Basal Cell Carcinoma
Galderma R&D 66
Load More Results